Legislation Details

File #: 21-01110    Version: 1 Name:
Type: Discussion Item Status: Completed
File created: 12/9/2021 In control: City Council Special Meeting
On agenda: 12/16/2021 Final action: 12/16/2021
Enactment date: Enactment #:
Title: ATTORNEY-CLIENT PRIVATE SESSION TO DISCUSS PENDING LITIGATION IN THE CASE OF IN RE: NATIONAL PRESCRIPTION OPIATE LITIGATION, MDL NO. 2804 (N.D. OHIO)
Sponsors: Ann Hill
Attachments: 1. Florida Opioid Allocation and Statewide Response Agreement, 2. Settlement Participation Form – Janssen, 3. Settlement Participation Form – McKesson Corporation Cardinal Health Inc. and AmerisourceBergen Corporation, 4. PROOF OF PUBLICATION

DISCUSSION ITEM

 

SPONSOR:                     City Council President Ann Hill

 

SUBJECT:  

 

title

ATTORNEY-CLIENT PRIVATE SESSION TO DISCUSS PENDING LITIGATION IN THE CASE OF IN RE: NATIONAL PRESCRIPTION OPIATE LITIGATION, MDL NO. 2804 (N.D. OHIO)

end                                                        

 

SUMMARY:

                                          

The City of Pensacola joined the Opioid Litigation in 2017.  The State of Florida, among other states, and almost 100 political subdivisions within Florida have filed suit against manufacturers and distributors of prescription opioids.  Settlement negotiations have been ongoing between the States and those various manufacturers and distributors.

 

It is therefore the recommendation of the City Attorney that an attorney-client session be held for City Council and its attorneys to discuss settlement options in accordance with Section 286.011(8), Florida Statutes. In compliance with the statute requirements, reasonable public notice was given.

 

This will be a private meeting with Council’s attorneys to discuss this pending litigation.

 

PRIOR ACTION:                     

 

June 30, 2021 - Attorney-Client Private Session was held to discuss the pending litigation.

 

STAFF CONTACT:

 

Don Kraher, Council Executive

 

ATTACHMENTS:

 

1)                     Florida Opioid Allocation and Statewide Response Agreement
2)
                     Settlement Participation Form - Janssen
3)
                     Settlement Participation Form - McKesson Corporation, Cardinal Health, Inc., and AmerisourceBergen Corporation

 

PRESENTATION:     No